Armed with clinical data suggesting that genetic testing should have federal oversight, three nonprofit groups this week asked the Centers for Medicaid and Medicare Services to resume its plan to regulate such tests under the Clinical Laboratories Improvement Act rules after it said in August it would end its plan to start a genetic testing specialty.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.